Viewing StudyNCT06336330

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06336330
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2024-03-22
Brief Title: Real-world Study on Dapagliflozin Usage in Patients With Heart Failure HF in Germany
Sponsor: AstraZeneca
Organization: AstraZeneca
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Heart Failure
Heart Diseases
Cardiovascular Diseases
Keywords:
Name View
Real-World View
Heart Failure with preserved ejection fraction HFpEF View
Heart Failure with mildly reduced ejection fraction HFmrEF View
Heart Failure with Reduced Ejection Fraction HFrEF View
Dapagliflozin View